Piribo: New Report on the Women's Health Pharmaceutical Market to 2011
Posted on: Wednesday, 9 May 2007, 09:00 CDT
Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has just added to its collection a key market report entitled The Women's Health Market Outlook to 2011 (http://www.piribo.com/search/results.html?k=rbi130&x=0&y=0). This new 224 page report provides analysis of the current and future market for women's health drugs across all major indications osteoporosis, infertility, uterine fibroids, endometriosis, urinary incontinence and gynaecological infections.
Key findings of this new report include:
- The leading hormonal contraceptive brand in 2005 was Schering AG's Yasmin which accrued $666m in sales.
- GSK's Boniva (ibandronate) indicated for the treatment of osteoporosis is forecast to accrue $1,309m by the end of the forecast period in 2011.
- Although Merck held the leading position among competing companies in the WH market in 2005, its marketed franchise comprises of a lone product, Fosamax, with an indication in osteoporosis Fosamax and its reformulated counter part Fosamax PLUS D which accrued combined sales of $2,845m in 2005.
This report, published by Datamonitor and available from Piribo.com, will help the reader forecast sales of the major products in the women's health sector and evaluate the potential market share of leading companies.
The report, with 25 figures and 65 tables, contains profiles of major companies operating in this fast moving area, including Akzo Nobel/Organon, Barr, Bayer-Schering Pharma, Johnson & Johnson, Merck, Novartis, Pfizer, Procter & Gamble, Watson and Wyeth. The following are examined for each company; sales focus by drug class, marketed product portfolio, R&D pipeline and growth potential.
Content in brief
- Executive Summary
- Chapter 1 Epidemiology of Women's Health
- Chapter 2 Global market analysis
- Chapter 3 Pipeline analysis
- Chapter 4 Competitive landscape
- Chapter 5 Appendix
"The Women's Health Market Outlook to 2011" is available from Piribo priced at £1,495. For more information, go to: http://www.piribo.com/publications/therapeutic/ womens_health_market_2011.html
About Piribo
Piribo is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 6,000 English language titles including, market reports, studies and books and is the UK's largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.
Source: Business Wire
Related Articles
- Examine in Detail China's Pharmaceutical Market and Health Care Reform
- The Report 'China Alcohol Market Report 2008' Provides Statistics of the Sales Scope of Such Alcohol and Provides Predictions on Their Market Size From 2007 to 2011
- Ibis Technology Selects Investment Banker to Pursue Potential Sale of the Company
- Infonetics Research: Cable Broadband Aggregation Equipment Market to Hit $1.4B in 2011; Sales Up 13% in 4Q07
- 2007 Essentials of the US Hospital IT Market - Revenue Cycle Management Chapter
- Pacific Energy &Amp; Mining Announces Negotiations for the Sale of the Company
- Focus on the Diet Foods Market: Strategic Overview, Market Analysis, Company Profiles and Forecasts to 2011
- Organic Food and Beverages, Food Intolerance Products, Slimming Products and Fortified/Functional Food and Beverages Are Featured Inside 'the World Market for Health and Wellness Products Report'
- Milwaukee Ice Plant Closed As Result of Sale to Canadian Company
- Sweet Success Returns to Texas Retail Market at One of America's Largest Convenience Store Chains; Company Continues Rollout of Revolutionary Health Shakes in Leading Markets
 |
 |
User Comments (0)
RSS Feeds